Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
Narayan D. Chaurasiya, Francisco León, Ilias Muhammad, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4297-4297
Open Access | Times Cited: 46
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder
Sunil Kumar, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6908-6917
Open Access | Times Cited: 29
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 9
The pivotal role of the carbonyl group in methoxy chalcones: comprehensive analyses of the structure and computational insights into binding affinity towards monoamine oxidase enzymes
Keshav Kumar Harish, Hussien Ahmed Khamees, Keerthikumara Venkatesha, et al.
Molecular Systems Design & Engineering (2025)
Closed Access | Times Cited: 1
Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—An updated review
Vishal Payyalot Koyiparambath, Prayaga Rajappan Krishnendu, T. M. Rangarajan, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 4, pp. 655-673
Closed Access | Times Cited: 43
Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease
Mohamed A. Abdelgawad, Jong‐Min Oh, Della Grace Thomas Parambi, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133545-133545
Closed Access | Times Cited: 34
Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors
Sunil Kumar, Ratul Bhowmik, Jong‐Min Oh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations
Jisna Jose, Jibin K. Varughese, Mohammad K. Parvez, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 6
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew, Jong‐Min Oh, Roua S. Baty, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 38855-38866
Open Access | Times Cited: 40
Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
Nisha Abdul Rehuman, Jong‐Min Oh, Lekshmi R. Nath, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 28182-28193
Open Access | Times Cited: 39
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
Rani Sasidharan, Bo Hyun Eom, Jeong Hyun Heo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 188-197
Open Access | Times Cited: 37
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
Sachithra Thazhathuveedu Sudevan, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Structure-Based Design of Novel MAO-B Inhibitors: A Review
Emilio Mateev, Maya Georgieva, Alexandrina Mateeva, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4814-4814
Open Access | Times Cited: 13
Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials
Sophia M. Villa, J.E. Heckman, Debasish Bandyopadhyay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9623-9623
Open Access | Times Cited: 5
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 31
Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors
Marco Mellado, César González, Jaime Mella, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104689-104689
Closed Access | Times Cited: 30
The metal sensing applications of chalcones: The synthesis, characterization and theoretical calculations
Hüseyin Karaca, Sözcan Kazancı
Journal of Molecular Structure (2021) Vol. 1248, pp. 131454-131454
Closed Access | Times Cited: 30
Structure and Cooperativity in Substrate–Enzyme Interactions: Perspectives on Enzyme Engineering and Inhibitor Design
Eerappa Rajakumara, Suman Abhishek, Kulhar Nitin, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 2, pp. 266-280
Closed Access | Times Cited: 22
Mitochondria targeting fluorescent probe for MAO-A and the application in the development of drug candidate for neuroinflammation
Jia‐Rong Wu, Chaoyan Han, Xudong Cao, et al.
Analytica Chimica Acta (2022) Vol. 1199, pp. 339573-339573
Closed Access | Times Cited: 22
An updated patent review on monoamine oxidase (MAO) inhibitors
Paolo Guglielmi, Simone Carradori, Ilaria D’Agostino, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 849-883
Closed Access | Times Cited: 22
Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 847-847
Open Access | Times Cited: 21
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors
Sachithra Thazhathuveedu Sudevan, T. M. Rangarajan, Abdullah G. Al‐Sehemi, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 8
Closed Access | Times Cited: 20
Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
Ashraf K. El‐Damasy, Jong‐Eun Park, Hyun Ji Kim, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 83-83
Open Access | Times Cited: 12
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
A Comprehensive Review of The Molecular Dynamic Study Of Chalcones, Coumarins and Chromones as Selective MAO‐B Inhibitors [2015‐Till Date]
Riya Rachel Thomas, Namitha Chandran, Della Grace Thomas Parambi, et al.
ChemistrySelect (2024) Vol. 9, Iss. 27
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top